Ionis Pharmaceuticals Inc Strategic Asset Allocation Index
Ionis Pharmaceuticals Inc strategic asset allocation index. Ionis Pharmaceuticals Inc (IONS) has a Strategic Asset Allocation Index of 21.4% as of June 2023. Strategic assets (PP&E of $91.63 Million plus long-term investments of $-) total $91.63 Million, measured against net assets of $428.30 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Ionis Pharmaceuticals Inc (IONS) tangible equity ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Ionis Pharmaceuticals Inc (2000–2022)
Strategic asset allocation index of Ionis Pharmaceuticals Inc from 2000 to 2022. This chart shows how Ionis Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of June 2023, the index stands at 21.4%, representing strategic assets of $91.63 Million against net assets of $428.30 Million USD.
Ionis Pharmaceuticals Inc Strategic Asset Allocation Index by Year (2000–2022)
Ionis Pharmaceuticals Inc strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Ionis Pharmaceuticals Inc from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Ionis Pharmaceuticals Inc worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 13.0% | $74.29 Million | $74.29 Million | $- | $572.89 Million | ▼ -10.1 pp |
| 2021 | 23.1% | $178.07 Million | $178.07 Million | $- | $772.00 Million | ▲ +1.6 pp |
| 2020 | 21.5% | $181.08 Million | $181.08 Million | $- | $843.00 Million | ▲ +11.8 pp |
| 2019 | 9.7% | $163.65 Million | $153.65 Million | $10.00 Million | $1.69 Billion | ▼ -1.4 pp |
| 2018 | 11.1% | $132.16 Million | $132.16 Million | $- | $1.19 Billion | ▼ -18.0 pp |
| 2017 | 29.1% | $121.91 Million | $121.91 Million | $- | $418.72 Million | ▼ -64.1 pp |
| 2016 | 93.3% | $92.84 Million | $92.84 Million | $- | $99.56 Million | ▲ +48.3 pp |
| 2015 | 44.9% | $90.23 Million | $90.23 Million | $- | $200.79 Million | ▲ +10.4 pp |
| 2014 | 34.5% | $88.96 Million | $88.96 Million | $- | $257.78 Million | ▲ +11.7 pp |
| 2013 | 22.8% | $86.20 Million | $86.20 Million | $- | $378.39 Million | ▼ -27.1 pp |
| 2012 | 49.8% | $91.08 Million | $91.08 Million | $- | $182.77 Million | ▼ -6.5 pp |
| 2011 | 56.4% | $96.61 Million | $96.61 Million | $- | $171.43 Million | ▲ +41.8 pp |
| 2010 | 14.6% | $35.70 Million | $35.70 Million | $- | $244.54 Million | ▲ +5.5 pp |
| 2009 | 9.1% | $27.34 Million | $27.34 Million | $- | $302.06 Million | ▼ -7.6 pp |
| 2008 | 16.7% | $17.37 Million | $17.37 Million | $- | $104.25 Million | ▼ -53.0 pp |
| 2007 | 69.6% | $7.13 Million | $7.13 Million | $- | $10.24 Million | ▲ +62.3 pp |
| 2006 | 7.3% | $7.16 Million | $7.16 Million | $- | $97.90 Million | ▼ -335.3 pp |
| 2005 | 342.6% | $9.13 Million | $9.13 Million | $- | $2.67 Million | ▲ +290.8 pp |
| 2003 | 51.8% | $34.79 Million | $34.79 Million | $- | $67.18 Million | ▲ +13.8 pp |
| 2002 | 38.0% | $59.09 Million | $59.09 Million | $- | $155.48 Million | ▲ +25.3 pp |
| 2001 | 12.7% | $28.25 Million | $28.25 Million | $- | $223.10 Million | ▼ -21.4 pp |
| 2000 | 34.1% | $22.62 Million | $22.62 Million | $- | $66.37 Million | — |